Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Tables)
|
6 Months Ended |
Dec. 31, 2019 |
| Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Tables) |
|
| Schedule of stock option activity |
| | Number of
Options | | | Weighted Average
Exercise Price | | | Weighted Average
Remaining Contractual Life (Years) | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | Outstanding at June 30, 2018 | | | 41,643,571 | | | $ | 0.22 | | | | 2.76 | | | $ | 17,523,113 | | Granted | | | 1,195,826 | | | $ | 0.31 | | | | 7.64 | | | | | | Exercised | | | (909,090 | ) | | $ | 0.11 | | | | | | | | | | Forfeited/expired | | | (19,260,424 | ) | | $ | 0.21 | | | | | | | | | | Outstanding at June 30, 2019 | | | 22,669,883 | | | $ | 0.24 | | | | 2.41 | | | $ | 1,340,000 | | Granted | | | 790,826 | | | $ | 0.13 | | | | 10.0 | | | | | | Exercised | | | - | | | $ | - | | | | - | | | | | | Forfeited/expired | | | (387,165 | ) | | $ | 0.70 | | | | - | | | | | | Outstanding at December 31, 2019 | | | 23,073,544 | | | $ | 0.23 | | | | 2.17 | | | $ | - | | Exercisable at December 31, 2019 | | | 21,667,478 | | | $ | 0.23 | | | | 1.74 | | | $ | - | | Unvested stock options at December 31, 2019 | | | 1,406,066 | | | $ | 0.23 | | | | 8.76 | | | $ | - | |
|
| Schedule of Restricted Stock Award Activity |
| | | | | Weighted | | | | | | | Average | | | | Number of | | | Grant Date | | | | Shares | | | Fair Value | | Total awards outstanding at June 30, 2018 | | | 1,208,157 | | | $ | 0.72 | | Total shares granted | | | 1,130,061 | | | $ | 0.40 | | Total shares vested | | | (597,263 | ) | | $ | 0.72 | | Total shares forfeited | | | (11,667 | ) | | $ | 0.76 | | Total unvested shares outstanding at June 30, 2019 | | | 1,729,288 | | | $ | 0.51 | | | | | | | | | | | Total shares granted | | | 1,125,061 | | | $ | 0.13 | | Total shares vested | | | (1,137,561 | ) | | $ | 0.56 | | Total shares forfeited | | | - | | | $ | - | | Total unvested shares outstanding at December 31, 2019 | | | 1,716,788 | | | $ | 0.23 | |
|
| Schedule of vesting outstanding restricted stock |
| | Year Ending June 30, | | | | 2020 | | | 2021 | | | 2022 | | | 2023 | | | Total | | Scheduled vesting | | | 12,500 | | | | 1,125,062 | | | | 572,262 | | | | 19,464 | | | | 1,729,288 | |
|
| Schedule of outstanding Series B preferred stock warrants |
| | Warrants | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | Outstanding at June 30, 2018 | | | | | | $ | - | | | | - | | | $ | - | | | | | | | | | | | | | | | | | | | Granted | | | 10,500 | | | | 982.50 | | | | 2.00 | | | | | | Exercised | | | (2,780 | ) | | | 982.50 | | | | 2.00 | | | | | | Expired | | | - | | | | - | | | | | | | | | | Outstanding at June 30, 2019 | | | 7,720 | | | $ | 985.50 | | | | 1.21 | | | $ | 752,700 | | | | | | | | | | | | | | | | | | | Granted | | | - | | | | - | | | | - | | | | | | Exercised | | | (1,192 | ) | | | 966.16 | | | | 1.43 | | | | | | Expired | | | - | | | | - | | | | | | | | | | Outstanding at September 30, 2019 | | | 6,528 | | | $ | 850.00 | | | | 2.00 | | | $ | 1,501,440 | |
|
| Schedule of fair value of the warrants assumptions |
| | Year Ended June 30, | | | | 2019 | | | 2018 | | Expected term (in years) | | 5 - 10 | | | | 3 | | Expected stock price volatility | | 67.34% - 104.11% | | | | 82.36 | % | Risk-free interest rate | | 2.51% - 2.86% | | | | 2.73 | % | Expected dividend yield | | | 0 | | | | 0 | |
|
| Schedule of outstanding common stock warrants |
| | Warrants | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (Years) | | | Aggregate Intrinsic Value | | | | | | | | | | | | | | | Outstanding at June 30, 2018 | | | 8,000,000 | | | $ | 0.38 | | | | 5.0 | | | $ | - | | | | | | | | | | | | | | | | | | | Extended | | | - | | | | - | | | | - | | | | | | Granted | | | - | | | | - | | | | - | | | | | | Exercised | | | - | | | | - | | | | - | | | | | | Expired | | | - | | | | - | | | | - | | | | | | Outstanding at June 30, 2019 | | | 8,000,000 | | | $ | 0.38 | | | | 4.0 | | | $ | - | | | | | | | | | | | | | | | | | | | Extended | | | - | | | | - | | | | - | | | | | | Granted | | | - | | | | - | | | | - | | | | | | Exercised | | | - | | | | - | | | | - | | | | | | Expired | | | - | | | | - | | | | - | | | | | | Outstanding at December 31, 2019 | | | 8,000,000 | | | $ | 0.38 | | | | 3.5 | | | $ | - | |
|